Price T Rowe Associates Inc. MD Has $1.40 Million Stock Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Price T Rowe Associates Inc. MD increased its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 8.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 66,144 shares of the company’s stock after acquiring an additional 5,327 shares during the quarter. Price T Rowe Associates Inc. MD owned about 0.05% of Surgery Partners worth $1,401,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Wells Fargo & Company MN raised its stake in shares of Surgery Partners by 1.4% in the fourth quarter. Wells Fargo & Company MN now owns 56,931 shares of the company’s stock valued at $1,205,000 after purchasing an additional 783 shares in the last quarter. MeadowBrook Investment Advisors LLC increased its holdings in Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock valued at $218,000 after buying an additional 1,460 shares during the period. KBC Group NV raised its stake in shares of Surgery Partners by 66.1% in the 4th quarter. KBC Group NV now owns 3,962 shares of the company’s stock valued at $84,000 after buying an additional 1,577 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of Surgery Partners by 1.3% during the 4th quarter. Rhumbline Advisers now owns 121,852 shares of the company’s stock worth $2,580,000 after acquiring an additional 1,588 shares during the period. Finally, MetLife Investment Management LLC boosted its position in shares of Surgery Partners by 6.1% during the 4th quarter. MetLife Investment Management LLC now owns 47,027 shares of the company’s stock valued at $996,000 after acquiring an additional 2,684 shares in the last quarter.

Surgery Partners Price Performance

Shares of SGRY stock opened at $22.20 on Friday. Surgery Partners, Inc. has a 52 week low of $19.50 and a 52 week high of $33.97. The stock has a market capitalization of $2.85 billion, a PE ratio of -46.25, a PEG ratio of 19.21 and a beta of 1.96. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The stock’s fifty day moving average is $22.61 and its 200-day moving average is $23.48.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.01. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $864.40 million for the quarter, compared to analyst estimates of $828.09 million. Equities research analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on SGRY. Benchmark reissued a “buy” rating and issued a $35.00 price target on shares of Surgery Partners in a research report on Monday, April 21st. Royal Bank of Canada restated an “outperform” rating and set a $35.00 target price on shares of Surgery Partners in a research report on Tuesday, March 25th. Finally, Macquarie decreased their price target on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Surgery Partners currently has a consensus rating of “Moderate Buy” and an average target price of $34.75.

Insider Activity

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of the business’s stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $24.09, for a total transaction of $76,028.04. Following the completion of the sale, the insider now directly owns 63,408 shares of the company’s stock, valued at approximately $1,527,498.72. The trade was a 4.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO David T. Doherty sold 6,733 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.02, for a total transaction of $161,726.66. Following the completion of the transaction, the chief financial officer now directly owns 150,868 shares in the company, valued at $3,623,849.36. This trade represents a 4.27 % decrease in their position. The disclosure for this sale can be found here. 2.30% of the stock is currently owned by insiders.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.